Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (41-50 of 378) with videos related to

Pageof 38
Sort By:
The Journal of Invasive Cardiology|June 2, 2015
Clinical impact of second-generation everolimus-eluting stents compared with first-generation drug-eluting stents in diabetic patients undergoing multivessel percutaneous coronary interventionLakshmana Pendyala, Joshua Loh, Hironori Kitabata, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 17, 2012
Intravascular ultrasound lumen area parameters for assessment of physiological ischemia by fractional flow reserve in intermediate coronary artery stenosisItsik Ben-Dor, Rebecca Torguson, Teshome Deksissa, et al.
Journal of Interventional Cardiology|December 18, 2012
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III)Ron Waksman, Olivier Bertrand, Mitchell Driesman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2014
The impact of live case transmission on patient outcomes during transcatheter aortic valve replacement: results from the VERITAS studyRon Waksman, Martyn Thomas, Steffen Gloekler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virusSalem Badr, Sa'ar Minha, Hironori Kitabata, et al.
American Heart Journal|July 3, 2013
Red cell distribution width as a bleeding predictor after percutaneous coronary interventionOmid Fatemi, Rebecca Torguson, Fang Chen, et al.
Expert Opinion on Drug Delivery|February 19, 2014
Current application and bioavailability of drug-eluting stentsRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 15, 2015
Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosisHideaki Ota, Michael Mahmoudi, Hironori Kitabata, et al.
Journal of Interventional Cardiology|May 4, 2011
Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular interventionNicholas Hanna, Paul Fiorilli, Michael A Gaglia, et al.
Pageof 38

Showing results (41-50 of 378) with videos related to

Sort By:
Pageof 38
The Journal of Invasive Cardiology|June 2, 2015
Clinical impact of second-generation everolimus-eluting stents compared with first-generation drug-eluting stents in diabetic patients undergoing multivessel percutaneous coronary interventionLakshmana Pendyala, Joshua Loh, Hironori Kitabata, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 17, 2012
Intravascular ultrasound lumen area parameters for assessment of physiological ischemia by fractional flow reserve in intermediate coronary artery stenosisItsik Ben-Dor, Rebecca Torguson, Teshome Deksissa, et al.
Journal of Interventional Cardiology|December 18, 2012
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III)Ron Waksman, Olivier Bertrand, Mitchell Driesman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 2, 2014
The impact of live case transmission on patient outcomes during transcatheter aortic valve replacement: results from the VERITAS studyRon Waksman, Martyn Thomas, Steffen Gloekler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trialJoshua P Loh, Pieter R Stella, Giuseppe Sangiorgi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virusSalem Badr, Sa'ar Minha, Hironori Kitabata, et al.
American Heart Journal|July 3, 2013
Red cell distribution width as a bleeding predictor after percutaneous coronary interventionOmid Fatemi, Rebecca Torguson, Fang Chen, et al.
Expert Opinion on Drug Delivery|February 19, 2014
Current application and bioavailability of drug-eluting stentsRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 15, 2015
Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosisHideaki Ota, Michael Mahmoudi, Hironori Kitabata, et al.
Journal of Interventional Cardiology|May 4, 2011
Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular interventionNicholas Hanna, Paul Fiorilli, Michael A Gaglia, et al.
Pageof 38